
StartUp Health community member Chuck Papageorgiou is CEO of NeuroEM Therapeutics, a leading clinical-stage biotechnology research company focused on commercializing its proprietary Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF) technologies against Alzheimer’s disease and cognitive decline.
Blog
+2

Aug 7, 2026
•
5 min read
A wave of non-drug, technology-driven therapies is reshaping what's possible for the millions of families facing Alzheimer's – and StartUp Health's Alzheimer's Moonshot Community is helping lead the way.

Free stories, podcasts & videos from the StartUp Health community direct to your inbox
Disclaimer: This site contains ads and affiliate links. Our content is supported in part by readers like you. If you buy after clicking a link, we may get a commission without costing you extra.